Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Cerebral infarction? 123 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Cerebral infarction have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.3% of all adverse event reports for EMPAGLIFLOZIN.

123
Reports of Cerebral infarction with EMPAGLIFLOZIN
0.3%
of all EMPAGLIFLOZIN reports
11
Deaths
81
Hospitalizations

How Dangerous Is Cerebral infarction From EMPAGLIFLOZIN?

Of the 123 reports, 11 (8.9%) resulted in death, 81 (65.9%) required hospitalization, and 16 (13.0%) were considered life-threatening.

Is Cerebral infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 123 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Cerebral infarction?

RIVAROXABAN (1,367) APIXABAN (937) DABIGATRAN ETEXILATE (713) ASPIRIN (535) EDOXABAN (419) CLOPIDOGREL BISULFATE (315) PEMBROLIZUMAB (295) BEVACIZUMAB (269) METHOTREXATE (265) NIVOLUMAB (262)

Which EMPAGLIFLOZIN Alternatives Have Lower Cerebral infarction Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Cerebral infarction Reports All Drugs Causing Cerebral infarction EMPAGLIFLOZIN Demographics